IHS Chemical Week

People & Business :: M&A

Claris Lifesciences forms joint venture with Japanese firms

10:08 PM MDT | July 31, 2013 | Natasha Alperowicz

Claris Lifesciences (Ahmedabad, India) says it has completed the transfer of its infusion business for India and emerging markets to Claris-Otsuka, a joint venture with Otsuka Pharmaceuticals Factory (Tokyo) and Mitsui & Co. Claris received 10.5 billion Indian rupees ($172.9 million) as part of the deal. Claris-Otsuka is valued at IR13.13 billion, Claris says.   The infusion business includes common solutions, anti-infectives, plasma volume expanders and nutrition therapies. Claris has transferred 2 plants to the joint venture in which Claris holds 20%...

This information is only available to Chemical Week subscribers.


Forgot your user ID or password?
Click here to have it sent to you.

Not an IHS Chemical Week member yet?

Here's why you should be:

  • 31 issues of Chemical Week magazine in print or digital format
  • Critical daily news and analysis on chemweek.com
  • Free mobile edition 
  • 20+ years of online archives
  • Topical e-newsletters that capture the most impactful events
  • Special issues with a regional or company focus
  • Global Outlook issue

Subscribe now

100% Satisfaction Guarantee
If at any time you are not completely satisfied with IHS Chemical Week, simply notify us and we'll refund the balance of your paid subscription - no problem.

Learn more about group subscriptions and site licenses.


contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2015 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa